Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Fig 2

Research Article

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats

Figure 2

Temporal changes in body weights (a) over the 12-week experimental period; body weight gain in COPD preparation period (b) and AE-RW-COPD periods (c) in each group. AE: acute exacerbation; BYG: Bufei Yishen Granule; COPD: chronic obstructive pulmonary disease; MXF: moxifloxacin; NS: normal saline; RW: risk window; TSG: Tongsai Granule; STL: salbutamol. . Repetitive measurement deviation analysis of body weights: . , versus Control group; , versus the COPD group; , versus AECOPD group; , versus TSG/BYG group; , versus MXF+STL/STL group.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.